Global Opioid Induced Constipation (OIC) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Opioid Induced Constipation (OIC) Drugs market size was valued at USD 2604.3 million in 2023 and is forecast to a readjusted size of USD 3520.9 million by 2030 with a CAGR of 4.4% during review period.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
The Global Info Research report includes an overview of the development of the Opioid Induced Constipation (OIC) Drugs industry chain, the market status of Hospital Pharmacies (Lubiprostone, Methyl Naltrexone Bromide), Retail Pharmacies (Lubiprostone, Methyl Naltrexone Bromide), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioid Induced Constipation (OIC) Drugs.
Regionally, the report analyzes the Opioid Induced Constipation (OIC) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioid Induced Constipation (OIC) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Opioid Induced Constipation (OIC) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Opioid Induced Constipation (OIC) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Lubiprostone, Methyl Naltrexone Bromide).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Opioid Induced Constipation (OIC) Drugs market.
Regional Analysis: The report involves examining the Opioid Induced Constipation (OIC) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Opioid Induced Constipation (OIC) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Opioid Induced Constipation (OIC) Drugs:
Company Analysis: Report covers individual Opioid Induced Constipation (OIC) Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Opioid Induced Constipation (OIC) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Opioid Induced Constipation (OIC) Drugs. It assesses the current state, advancements, and potential future developments in Opioid Induced Constipation (OIC) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Opioid Induced Constipation (OIC) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Opioid Induced Constipation (OIC) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Opioid Induced Constipation (OIC) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drugs, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drugs from 2019 to 2024.
Chapter 3, the Opioid Induced Constipation (OIC) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation (OIC) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Opioid Induced Constipation (OIC) Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid Induced Constipation (OIC) Drugs.
Chapter 14 and 15, to describe Opioid Induced Constipation (OIC) Drugs sales channel, distributors, customers, research findings and conclusion.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
The Global Info Research report includes an overview of the development of the Opioid Induced Constipation (OIC) Drugs industry chain, the market status of Hospital Pharmacies (Lubiprostone, Methyl Naltrexone Bromide), Retail Pharmacies (Lubiprostone, Methyl Naltrexone Bromide), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Opioid Induced Constipation (OIC) Drugs.
Regionally, the report analyzes the Opioid Induced Constipation (OIC) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Opioid Induced Constipation (OIC) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Opioid Induced Constipation (OIC) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Opioid Induced Constipation (OIC) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Lubiprostone, Methyl Naltrexone Bromide).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Opioid Induced Constipation (OIC) Drugs market.
Regional Analysis: The report involves examining the Opioid Induced Constipation (OIC) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Opioid Induced Constipation (OIC) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Opioid Induced Constipation (OIC) Drugs:
Company Analysis: Report covers individual Opioid Induced Constipation (OIC) Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Opioid Induced Constipation (OIC) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Opioid Induced Constipation (OIC) Drugs. It assesses the current state, advancements, and potential future developments in Opioid Induced Constipation (OIC) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Opioid Induced Constipation (OIC) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Opioid Induced Constipation (OIC) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Ironwood Pharmaceuticals Inc
- Daiichi Sankyo Co Ltd
- Pfizer
- Progenics Pharmaceuticals Inc
- Shionogi & Co., Ltd
- Allergan Plc
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma AG
- Mundipharma International Limited
- Ono Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma Inc
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Opioid Induced Constipation (OIC) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation (OIC) Drugs, with price, sales, revenue and global market share of Opioid Induced Constipation (OIC) Drugs from 2019 to 2024.
Chapter 3, the Opioid Induced Constipation (OIC) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation (OIC) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Opioid Induced Constipation (OIC) Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioid Induced Constipation (OIC) Drugs.
Chapter 14 and 15, to describe Opioid Induced Constipation (OIC) Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Lubiprostone
1.3.3 Methyl Naltrexone Bromide
1.3.4 Naldemedine
1.3.5 Alvimopan
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Opioid Induced Constipation (OIC) Drugs Market Size & Forecast
1.5.1 Global Opioid Induced Constipation (OIC) Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity (2019-2030)
1.5.3 Global Opioid Induced Constipation (OIC) Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Ironwood Pharmaceuticals Inc
2.1.1 Ironwood Pharmaceuticals Inc Details
2.1.2 Ironwood Pharmaceuticals Inc Major Business
2.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
2.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Ironwood Pharmaceuticals Inc Recent Developments/Updates
2.2 Daiichi Sankyo Co Ltd
2.2.1 Daiichi Sankyo Co Ltd Details
2.2.2 Daiichi Sankyo Co Ltd Major Business
2.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
2.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Product and Services
2.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments/Updates
2.4 Progenics Pharmaceuticals Inc
2.4.1 Progenics Pharmaceuticals Inc Details
2.4.2 Progenics Pharmaceuticals Inc Major Business
2.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
2.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Progenics Pharmaceuticals Inc Recent Developments/Updates
2.5 Shionogi & Co., Ltd
2.5.1 Shionogi & Co., Ltd Details
2.5.2 Shionogi & Co., Ltd Major Business
2.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
2.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shionogi & Co., Ltd Recent Developments/Updates
2.6 Allergan Plc
2.6.1 Allergan Plc Details
2.6.2 Allergan Plc Major Business
2.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product and Services
2.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Allergan Plc Recent Developments/Updates
2.7 Nektar Therapeutics
2.7.1 Nektar Therapeutics Details
2.7.2 Nektar Therapeutics Major Business
2.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
2.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Nektar Therapeutics Recent Developments/Updates
2.8 Purdue Pharma
2.8.1 Purdue Pharma Details
2.8.2 Purdue Pharma Major Business
2.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product and Services
2.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Purdue Pharma Recent Developments/Updates
2.9 S.L.A. Pharma AG
2.9.1 S.L.A. Pharma AG Details
2.9.2 S.L.A. Pharma AG Major Business
2.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product and Services
2.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 S.L.A. Pharma AG Recent Developments/Updates
2.10 Mundipharma International Limited
2.10.1 Mundipharma International Limited Details
2.10.2 Mundipharma International Limited Major Business
2.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product and Services
2.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mundipharma International Limited Recent Developments/Updates
2.11 Ono Pharmaceutical Co., Ltd
2.11.1 Ono Pharmaceutical Co., Ltd Details
2.11.2 Ono Pharmaceutical Co., Ltd Major Business
2.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
2.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.13 Theravance Biopharma Inc
2.13.1 Theravance Biopharma Inc Details
2.13.2 Theravance Biopharma Inc Major Business
2.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product and Services
2.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Theravance Biopharma Inc Recent Developments/Updates
2.14 Bausch Health
2.14.1 Bausch Health Details
2.14.2 Bausch Health Major Business
2.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
2.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bausch Health Recent Developments/Updates
2.15 Cosmo Pharmaceuticals SA
2.15.1 Cosmo Pharmaceuticals SA Details
2.15.2 Cosmo Pharmaceuticals SA Major Business
2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product and Services
2.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates
2.16 Daewoong Pharmaceutical
2.16.1 Daewoong Pharmaceutical Details
2.16.2 Daewoong Pharmaceutical Major Business
2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product and Services
2.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Daewoong Pharmaceutical Recent Developments/Updates
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business
2.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product and Services
2.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 C.B. Fleet Company Recent Developments/Updates
2.18 Sucampo Pharmaceuticals
2.18.1 Sucampo Pharmaceuticals Details
2.18.2 Sucampo Pharmaceuticals Major Business
2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
2.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Sucampo Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOID INDUCED CONSTIPATION (OIC) DRUGS BY MANUFACTURER
3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Opioid Induced Constipation (OIC) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2023
3.5 Opioid Induced Constipation (OIC) Drugs Market: Overall Company Footprint Analysis
3.5.1 Opioid Induced Constipation (OIC) Drugs Market: Region Footprint
3.5.2 Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
3.5.3 Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Region (2019-2030)
4.2 North America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.3 Europe Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.5 South America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
5.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type (2019-2030)
5.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
6.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2019-2030)
6.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
7.2 North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
7.3 North America Opioid Induced Constipation (OIC) Drugs Market Size by Country
7.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Country
8.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Region
9.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
10.2 South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
10.3 South America Opioid Induced Constipation (OIC) Drugs Market Size by Country
10.3.1 South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Size by Country
11.3.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Opioid Induced Constipation (OIC) Drugs Market Drivers
12.2 Opioid Induced Constipation (OIC) Drugs Market Restraints
12.3 Opioid Induced Constipation (OIC) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioid Induced Constipation (OIC) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioid Induced Constipation (OIC) Drugs
13.3 Opioid Induced Constipation (OIC) Drugs Production Process
13.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioid Induced Constipation (OIC) Drugs Typical Distributors
14.3 Opioid Induced Constipation (OIC) Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Lubiprostone
1.3.3 Methyl Naltrexone Bromide
1.3.4 Naldemedine
1.3.5 Alvimopan
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Opioid Induced Constipation (OIC) Drugs Market Size & Forecast
1.5.1 Global Opioid Induced Constipation (OIC) Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity (2019-2030)
1.5.3 Global Opioid Induced Constipation (OIC) Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Ironwood Pharmaceuticals Inc
2.1.1 Ironwood Pharmaceuticals Inc Details
2.1.2 Ironwood Pharmaceuticals Inc Major Business
2.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
2.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Ironwood Pharmaceuticals Inc Recent Developments/Updates
2.2 Daiichi Sankyo Co Ltd
2.2.1 Daiichi Sankyo Co Ltd Details
2.2.2 Daiichi Sankyo Co Ltd Major Business
2.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
2.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Product and Services
2.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments/Updates
2.4 Progenics Pharmaceuticals Inc
2.4.1 Progenics Pharmaceuticals Inc Details
2.4.2 Progenics Pharmaceuticals Inc Major Business
2.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
2.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Progenics Pharmaceuticals Inc Recent Developments/Updates
2.5 Shionogi & Co., Ltd
2.5.1 Shionogi & Co., Ltd Details
2.5.2 Shionogi & Co., Ltd Major Business
2.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
2.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shionogi & Co., Ltd Recent Developments/Updates
2.6 Allergan Plc
2.6.1 Allergan Plc Details
2.6.2 Allergan Plc Major Business
2.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product and Services
2.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Allergan Plc Recent Developments/Updates
2.7 Nektar Therapeutics
2.7.1 Nektar Therapeutics Details
2.7.2 Nektar Therapeutics Major Business
2.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
2.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Nektar Therapeutics Recent Developments/Updates
2.8 Purdue Pharma
2.8.1 Purdue Pharma Details
2.8.2 Purdue Pharma Major Business
2.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product and Services
2.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Purdue Pharma Recent Developments/Updates
2.9 S.L.A. Pharma AG
2.9.1 S.L.A. Pharma AG Details
2.9.2 S.L.A. Pharma AG Major Business
2.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product and Services
2.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 S.L.A. Pharma AG Recent Developments/Updates
2.10 Mundipharma International Limited
2.10.1 Mundipharma International Limited Details
2.10.2 Mundipharma International Limited Major Business
2.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product and Services
2.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Mundipharma International Limited Recent Developments/Updates
2.11 Ono Pharmaceutical Co., Ltd
2.11.1 Ono Pharmaceutical Co., Ltd Details
2.11.2 Ono Pharmaceutical Co., Ltd Major Business
2.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
2.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.13 Theravance Biopharma Inc
2.13.1 Theravance Biopharma Inc Details
2.13.2 Theravance Biopharma Inc Major Business
2.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product and Services
2.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Theravance Biopharma Inc Recent Developments/Updates
2.14 Bausch Health
2.14.1 Bausch Health Details
2.14.2 Bausch Health Major Business
2.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
2.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bausch Health Recent Developments/Updates
2.15 Cosmo Pharmaceuticals SA
2.15.1 Cosmo Pharmaceuticals SA Details
2.15.2 Cosmo Pharmaceuticals SA Major Business
2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product and Services
2.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates
2.16 Daewoong Pharmaceutical
2.16.1 Daewoong Pharmaceutical Details
2.16.2 Daewoong Pharmaceutical Major Business
2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product and Services
2.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Daewoong Pharmaceutical Recent Developments/Updates
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business
2.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product and Services
2.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 C.B. Fleet Company Recent Developments/Updates
2.18 Sucampo Pharmaceuticals
2.18.1 Sucampo Pharmaceuticals Details
2.18.2 Sucampo Pharmaceuticals Major Business
2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
2.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Sucampo Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOID INDUCED CONSTIPATION (OIC) DRUGS BY MANUFACTURER
3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Opioid Induced Constipation (OIC) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer Market Share in 2023
3.5 Opioid Induced Constipation (OIC) Drugs Market: Overall Company Footprint Analysis
3.5.1 Opioid Induced Constipation (OIC) Drugs Market: Region Footprint
3.5.2 Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
3.5.3 Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Region (2019-2030)
4.2 North America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.3 Europe Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.5 South America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
5.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type (2019-2030)
5.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
6.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2019-2030)
6.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
7.2 North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
7.3 North America Opioid Induced Constipation (OIC) Drugs Market Size by Country
7.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Opioid Induced Constipation (OIC) Drugs Market Size by Country
8.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Size by Region
9.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
10.2 South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
10.3 South America Opioid Induced Constipation (OIC) Drugs Market Size by Country
10.3.1 South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Market Size by Country
11.3.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Opioid Induced Constipation (OIC) Drugs Market Drivers
12.2 Opioid Induced Constipation (OIC) Drugs Market Restraints
12.3 Opioid Induced Constipation (OIC) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioid Induced Constipation (OIC) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioid Induced Constipation (OIC) Drugs
13.3 Opioid Induced Constipation (OIC) Drugs Production Process
13.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioid Induced Constipation (OIC) Drugs Typical Distributors
14.3 Opioid Induced Constipation (OIC) Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Ironwood Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood Pharmaceuticals Inc Major Business
Table 5. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 6. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Ironwood Pharmaceuticals Inc Recent Developments/Updates
Table 8. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Daiichi Sankyo Co Ltd Major Business
Table 10. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 11. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Opioid Induced Constipation (OIC) Drugs Product and Services
Table 16. Pfizer Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Pfizer Recent Developments/Updates
Table 18. Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 19. Progenics Pharmaceuticals Inc Major Business
Table 20. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 21. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Progenics Pharmaceuticals Inc Recent Developments/Updates
Table 23. Shionogi & Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Shionogi & Co., Ltd Major Business
Table 25. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 26. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Shionogi & Co., Ltd Recent Developments/Updates
Table 28. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 29. Allergan Plc Major Business
Table 30. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 31. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Allergan Plc Recent Developments/Updates
Table 33. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Nektar Therapeutics Major Business
Table 35. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
Table 36. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Nektar Therapeutics Recent Developments/Updates
Table 38. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Purdue Pharma Major Business
Table 40. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product and Services
Table 41. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Purdue Pharma Recent Developments/Updates
Table 43. S.L.A. Pharma AG Basic Information, Manufacturing Base and Competitors
Table 44. S.L.A. Pharma AG Major Business
Table 45. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product and Services
Table 46. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. S.L.A. Pharma AG Recent Developments/Updates
Table 48. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 49. Mundipharma International Limited Major Business
Table 50. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product and Services
Table 51. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Mundipharma International Limited Recent Developments/Updates
Table 53. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Ono Pharmaceutical Co., Ltd Major Business
Table 55. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 56. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 58. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 59. Takeda Pharmaceutical Company Limited Major Business
Table 60. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product and Services
Table 61. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 63. Theravance Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 64. Theravance Biopharma Inc Major Business
Table 65. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 66. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Theravance Biopharma Inc Recent Developments/Updates
Table 68. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 69. Bausch Health Major Business
Table 70. Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
Table 71. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Bausch Health Recent Developments/Updates
Table 73. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 74. Cosmo Pharmaceuticals SA Major Business
Table 75. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product and Services
Table 76. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Cosmo Pharmaceuticals SA Recent Developments/Updates
Table 78. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Daewoong Pharmaceutical Major Business
Table 80. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product and Services
Table 81. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Daewoong Pharmaceutical Recent Developments/Updates
Table 83. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 84. C.B. Fleet Company Major Business
Table 85. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product and Services
Table 86. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. C.B. Fleet Company Recent Developments/Updates
Table 88. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 89. Sucampo Pharmaceuticals Major Business
Table 90. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 91. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Sucampo Pharmaceuticals Recent Developments/Updates
Table 93. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 94. Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 95. Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 96. Market Position of Manufacturers in Opioid Induced Constipation (OIC) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 97. Head Office and Opioid Induced Constipation (OIC) Drugs Production Site of Key Manufacturer
Table 98. Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
Table 99. Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
Table 100. Opioid Induced Constipation (OIC) Drugs New Market Entrants and Barriers to Market Entry
Table 101. Opioid Induced Constipation (OIC) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 103. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 104. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 106. Global Opioid Induced Constipation (OIC) Drugs Average Price by Region (2019-2024) & (USD/Dose)
Table 107. Global Opioid Induced Constipation (OIC) Drugs Average Price by Region (2025-2030) & (USD/Dose)
Table 108. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 109. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 110. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2019-2024) & (USD/Dose)
Table 113. Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2025-2030) & (USD/Dose)
Table 114. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 115. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 116. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 117. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 118. Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2019-2024) & (USD/Dose)
Table 119. Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2025-2030) & (USD/Dose)
Table 120. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 121. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 122. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 123. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 124. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 125. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 126. North America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 127. North America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 129. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 130. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 131. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 132. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 133. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 134. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 137. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 138. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 139. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 140. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 141. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 142. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 143. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 144. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 145. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 146. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 147. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 148. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 149. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 150. South America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 151. South America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 152. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 153. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 154. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 155. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 156. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 157. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 158. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 159. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 160. Opioid Induced Constipation (OIC) Drugs Raw Material
Table 161. Key Manufacturers of Opioid Induced Constipation (OIC) Drugs Raw Materials
Table 162. Opioid Induced Constipation (OIC) Drugs Typical Distributors
Table 163. Opioid Induced Constipation (OIC) Drugs Typical Customers
Table 1. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Ironwood Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood Pharmaceuticals Inc Major Business
Table 5. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 6. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Ironwood Pharmaceuticals Inc Recent Developments/Updates
Table 8. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Daiichi Sankyo Co Ltd Major Business
Table 10. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 11. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Opioid Induced Constipation (OIC) Drugs Product and Services
Table 16. Pfizer Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Pfizer Recent Developments/Updates
Table 18. Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 19. Progenics Pharmaceuticals Inc Major Business
Table 20. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 21. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Progenics Pharmaceuticals Inc Recent Developments/Updates
Table 23. Shionogi & Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Shionogi & Co., Ltd Major Business
Table 25. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 26. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Shionogi & Co., Ltd Recent Developments/Updates
Table 28. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 29. Allergan Plc Major Business
Table 30. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 31. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Allergan Plc Recent Developments/Updates
Table 33. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Nektar Therapeutics Major Business
Table 35. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
Table 36. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Nektar Therapeutics Recent Developments/Updates
Table 38. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Purdue Pharma Major Business
Table 40. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product and Services
Table 41. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Purdue Pharma Recent Developments/Updates
Table 43. S.L.A. Pharma AG Basic Information, Manufacturing Base and Competitors
Table 44. S.L.A. Pharma AG Major Business
Table 45. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product and Services
Table 46. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. S.L.A. Pharma AG Recent Developments/Updates
Table 48. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 49. Mundipharma International Limited Major Business
Table 50. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product and Services
Table 51. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Mundipharma International Limited Recent Developments/Updates
Table 53. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Ono Pharmaceutical Co., Ltd Major Business
Table 55. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product and Services
Table 56. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 58. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 59. Takeda Pharmaceutical Company Limited Major Business
Table 60. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product and Services
Table 61. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 63. Theravance Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 64. Theravance Biopharma Inc Major Business
Table 65. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product and Services
Table 66. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Theravance Biopharma Inc Recent Developments/Updates
Table 68. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 69. Bausch Health Major Business
Table 70. Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
Table 71. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Bausch Health Recent Developments/Updates
Table 73. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 74. Cosmo Pharmaceuticals SA Major Business
Table 75. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product and Services
Table 76. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Cosmo Pharmaceuticals SA Recent Developments/Updates
Table 78. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Daewoong Pharmaceutical Major Business
Table 80. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product and Services
Table 81. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Daewoong Pharmaceutical Recent Developments/Updates
Table 83. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 84. C.B. Fleet Company Major Business
Table 85. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product and Services
Table 86. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. C.B. Fleet Company Recent Developments/Updates
Table 88. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 89. Sucampo Pharmaceuticals Major Business
Table 90. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 91. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Sucampo Pharmaceuticals Recent Developments/Updates
Table 93. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 94. Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 95. Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 96. Market Position of Manufacturers in Opioid Induced Constipation (OIC) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 97. Head Office and Opioid Induced Constipation (OIC) Drugs Production Site of Key Manufacturer
Table 98. Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
Table 99. Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
Table 100. Opioid Induced Constipation (OIC) Drugs New Market Entrants and Barriers to Market Entry
Table 101. Opioid Induced Constipation (OIC) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 103. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 104. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 106. Global Opioid Induced Constipation (OIC) Drugs Average Price by Region (2019-2024) & (USD/Dose)
Table 107. Global Opioid Induced Constipation (OIC) Drugs Average Price by Region (2025-2030) & (USD/Dose)
Table 108. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 109. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 110. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2019-2024) & (USD/Dose)
Table 113. Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2025-2030) & (USD/Dose)
Table 114. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 115. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 116. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 117. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 118. Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2019-2024) & (USD/Dose)
Table 119. Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2025-2030) & (USD/Dose)
Table 120. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 121. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 122. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 123. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 124. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 125. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 126. North America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 127. North America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 129. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 130. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 131. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 132. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 133. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 134. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 137. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 138. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 139. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 140. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 141. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 142. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 143. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 144. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 145. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 146. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 147. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 148. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 149. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 150. South America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 151. South America Opioid Induced Constipation (OIC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 152. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 153. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 154. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 155. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 156. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 157. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 158. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 159. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 160. Opioid Induced Constipation (OIC) Drugs Raw Material
Table 161. Key Manufacturers of Opioid Induced Constipation (OIC) Drugs Raw Materials
Table 162. Opioid Induced Constipation (OIC) Drugs Typical Distributors
Table 163. Opioid Induced Constipation (OIC) Drugs Typical Customers
LIST OF FIGURES
Figure 1. Opioid Induced Constipation (OIC) Drugs Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Type in 2023
Figure 4. Lubiprostone Examples
Figure 5. Methyl Naltrexone Bromide Examples
Figure 6. Naldemedine Examples
Figure 7. Alvimopan Examples
Figure 8. Others Examples
Figure 9. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Application in 2023
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global Opioid Induced Constipation (OIC) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Opioid Induced Constipation (OIC) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity (2019-2030) & (K Dose)
Figure 17. Global Opioid Induced Constipation (OIC) Drugs Average Price (2019-2030) & (USD/Dose)
Figure 18. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Opioid Induced Constipation (OIC) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2019-2030) & (USD/Dose)
Figure 33. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2019-2030) & (USD/Dose)
Figure 36. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Opioid Induced Constipation (OIC) Drugs Market Drivers
Figure 77. Opioid Induced Constipation (OIC) Drugs Market Restraints
Figure 78. Opioid Induced Constipation (OIC) Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drugs in 2023
Figure 81. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure 82. Opioid Induced Constipation (OIC) Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Opioid Induced Constipation (OIC) Drugs Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Type in 2023
Figure 4. Lubiprostone Examples
Figure 5. Methyl Naltrexone Bromide Examples
Figure 6. Naldemedine Examples
Figure 7. Alvimopan Examples
Figure 8. Others Examples
Figure 9. Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Application in 2023
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global Opioid Induced Constipation (OIC) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Opioid Induced Constipation (OIC) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity (2019-2030) & (K Dose)
Figure 17. Global Opioid Induced Constipation (OIC) Drugs Average Price (2019-2030) & (USD/Dose)
Figure 18. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Opioid Induced Constipation (OIC) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Opioid Induced Constipation (OIC) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Opioid Induced Constipation (OIC) Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Opioid Induced Constipation (OIC) Drugs Average Price by Type (2019-2030) & (USD/Dose)
Figure 33. Global Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Opioid Induced Constipation (OIC) Drugs Average Price by Application (2019-2030) & (USD/Dose)
Figure 36. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Opioid Induced Constipation (OIC) Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Opioid Induced Constipation (OIC) Drugs Market Drivers
Figure 77. Opioid Induced Constipation (OIC) Drugs Market Restraints
Figure 78. Opioid Induced Constipation (OIC) Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drugs in 2023
Figure 81. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure 82. Opioid Induced Constipation (OIC) Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
